v3.22.4
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (3,672,348) $ (2,773,441)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 27,345 12,577  
Amortization of debt discount 998,076 130,152  
Amortization of operating right-of-use asset 8,435    
Recovery of doubtful accounts, net   (25,157)  
Stock-based compensation 439,332 320,823  
Change in operating assets and liabilities      
Accounts receivables (1,092) 108,110  
Accounts receivables, a related party   10,198  
Inventories 66,125 59,423  
Other receivable and other current assets (419,771) (83,639)  
Prepayments (256,331) (238,750)  
Accounts payable 109,607 216,984  
Accounts payable, related parties (8,789) (151,608)  
Customer deposits 19,394 (144,797)  
Customer deposits, related parties   (148,085)  
Contract liability 115,402 42,644  
Other payables and accrued liabilities 21,236 (47,740)  
Other payable, related party 93,330    
Operating lease liability (8,347)    
Income tax payables 11,500 3,900  
Net cash used in operating activities (2,456,896) (2,708,406)  
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of equipment (34,399) (157,541)  
Net cash used in investing activities (34,399) (157,541)  
CASH FLOWS FROM FINANCING ACTIVITIES:      
Payments of deferred offering cost (15,000)    
Proceeds from issuance of common stock in initial public offering 8,235,110    
Payments of related party loan (1,203) (1,211)  
Proceeds from issuance of convertible notes 2,672,092 477,834  
Proceeds from issuance of convertible notes, related parties   240,444  
Repayment of senior note (65,000)    
(Repayment to) proceeds from related parties (1,621,499) 80,154  
Proceeds from third party loans 557,550 292,929  
Repayment to third party loans (1,951,041)    
Net cash provided by financing activities 7,811,008 1,090,150  
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS (157,130) (35,003)  
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS 5,162,583 (1,810,800)  
CASH AND CASH EQUIVALENTS, beginning of period 1,845,232 2,843,398 $ 2,843,398
CASH AND CASH EQUIVALENTS, end of period 7,007,815 1,032,598 $ 1,845,232
SUPPLEMENTAL CASH FLOWS INFORMATION      
Income taxes paid 0 0  
Interest paid 42,998 $ 65,594  
SUPPLEMENTAL NON-CASH FLOWS INFORMATION      
Offering costs paid in the prior period 93,536    
Beneficial conversion feature resulted from issuance of convertible notes 537,383    
Fair value of warrants issued to underwriter 175,349    
Fair value of warrants issued to consultant 856,170    
Fair value of common stock issued to consultant 439,332    
Recognition of operating right-of-use asset and lease liability 87,704    
Conversion of convertible note payable, net of unamortized discounts 14,097,414    
Conversion of convertible note payable, related parties $ 2,437,574